Tata India Pharma & Healthcare Fund - Growth - Direct Plan

Other Plans and Options
  • (-1.14%)Nav, as on 13-02-2026

  • Previous Nav

  • Net Change on 13-02-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Tata India Pharma & Healthcare Fund-Direct Plan-Growth -0.48 -3.14 5.88 23.72 16.37 13.15
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 5.88 23.72 16.37 0.71 1,239.57
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 8.05 23.26 15.86 0.93 7,875.40
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 7.09 27.60 17.76 1.02 6,658.41
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 5.56 25.43 17.09 0.92 3,822.73
UTI Healthcare Fund - Direct Plan - Growth Option Jan 01, 2013 8.83 25.52 16.11 1.30 1,055.01

Fund Holdings as on 31-January-2026

  • SUN PHARMACEUTICAL INDUSTRIES LTD.

  • MAX HEALTHCARE INSTITUTE LTD.

  • ABBOTT INDIA LTD.

  • DIVI LABORATORIES LTD.

  • HEALTHCARE GLOBAL ENTERPRISES LTD.

  • APOLLO HOSPITALS ENTERPRISE LTD.

  • CIPLA LTD.

  • RAINBOW CHILDRENS MEDICARE LTD.

  • MANKIND PHARMA LTD

  • BAYER CROPSCIENCE LTD.

  • METROPOLIS HEALTHCARE LTD.

  • KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD.

  • IPCA LABORATORIES LTD.

  • FORTIS HEALTHCARE LTD.

  • J.B.CHEMICALS & PHARMACEUTICALS LTD.

  • LUPIN LTD.

  • DR. LAL PATH LABS LTD.

  • SAI LIFE SCIENCES LTD

  • ALKEM LABORATORIES LTD.

  • SYNGENE INTERNATIONAL LTD.

  • AJANTA PHARMA LTD.

  • SANOFI INDIA LTD.

  • FDC LTD.

  • DR REDDYS LABORATORIES LTD.

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD.

  • VIJAYA DIAGNOSTIC CENTRE LTD.

  • NEULAND LABORATORIES LTD.

  • GLOBAL HEALTH LTD.

  • CORONA REMEDIES LTD

  • TORRENT PHARMACEUTICALS LTD.

  • CASH / NET CURRENT ASSET

  • HIKAL LTD.

  • A) REPO

  • DR. AGARWALS HEALTH CARE LTD.

  • JUBILANT PHARMOVA LTD

  • LAXMI DENTAL LIMITED

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Pesticides & Agrochemicals

  • Business Support

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

View More

About Tata India Pharma & Healthcare Fund

Scheme Analysis

Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹1,239.57 crore. Tata India Pharma & Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Tata India Pharma & Healthcare Fund ended down ₹-0.4(-1.14%)yesterday to ₹34.5599.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and

The Tata India Pharma & Healthcare Fund is managed by Rajat Srivastava .

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

022 6282 7777
service@tataamc.com
+91 (22) 22613782